Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) (FRA:RN3N)
ARNA
RN3N

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) (FRA:RN3N) is a biopharmaceutical company focused on developing novel, small molecule drugs with optimized receptor pharmacology designed to deliver broad clinical utility across multiple therapeutic areas. Arena’s proprietary pipeline includes potentially first- or best-in-class programs for which they own global commercial rights. Arena’s APD371, a CB2 agonist, is in clinical-stage studies. The CB2 receptor is part of the naturally occurring cannabinoid receptor system in our bodies.

92121
https://www.arenapharm.com/
1 (858) 453-7200
USA

Ratings

There are no reviews yet.

Post your review

Directions to listing

Send Message to listing owner

Arena Pharmaceuticals, Inc.